Hydroxyurea Gets DCGI Nod for Treatment of Sickle Cell Anaemia
Sickle cell anaemia (SCA) is a common genetic disorder among Indians affecting the red blood cells. It is transmitted by parents who carry a defective beta globin gene without suffering themselves. Close to 0.4 per cent of the population suffers from the disease while 10 per cent people are carriers who lead to birth of new SCA patients.